Answer
Oxaliplatin can cause QT prolongation, increasing the risk of ventricular arrhythmias including potentially fatal Torsade de Pointes; the QT interval should be monitored regularly before and after administration, and oxaliplatin should be discontinued if QT prolongation occurs.
Sources for this answer
- Oxaliplatin 5 mg/ml concentrate for solution for infusionRanbaxy (UK) Limited a Sun Pharmaceutical Company · emc · SmPC §4.4 Special warnings and precautions for use · Version 11Document updated
Sources checked